Mismatched Priorities Extend Lab Market Woes
Commercial landlords’ business model and small biotech companies’ needs are at odds, throwing obstacles in the paths of filling empty lab buildings and form the next generation of industry giants, alike.
Alexandria Sells Kendall Square Properties for $45M
Alexandria Real Estate Equities’ latest disposition activity took place in the East Cambridge life science hub with a $45 million sale at a Kendall Square property.
Takeda Offers Four Cambridge Buildings for Sublease
Takeda Pharmaceutical Co.’s move to its new Kendall Square tower is opening up big new blocks of availability in the Cambridge lab market.
Archrival Buys Alexandria Labs in Kendall Square for $250M
Alexandria Real Estate Equities sold three Kendall Square life science buildings to its archrival BioMed Realty for $250 million in a transaction between the nation’s two largest lab landlords.
Biogen Reportedly Scouts Volpe Move
Biogen is reportedly in negotiations to lease up to 500,000 square feet as the first tenant at MIT’s redevelopment of the Volpe Center property in Cambridge.
